Long QT syndrome 2

An autosomal dominant condition caused by mutation(s) in the KCNH2 gene, encoding potassium voltage-gated channel subfamily H member 2. It is characterized by a prolonged QT interval that may result in torsade de pointes, ventricular fibrillation and/or sudden cardiac death.

Also known as: LQT2, Long QT syndrome, acquired, reduced susceptibility to, long QT syndrome 2, long QT syndrome type 2, long QT syndrome 1/2, digenic, long QT syndrome 2, acquired, susceptibility to, long QT syndrome 2/3, digenic, long QT syndrome 2/5, digenic

3 clinical trials for this condition and its sub-types.